EUVIMEDEUVIMED entdecken
Leitlinie

1058 Evaluating Comprehensive Best Medical Therapy and Lifestyle Optimisation in Chronic Limb-Threatening Ischaemia: An Integrated Audit of Adherence to ESVS 2023 Cardiovascular Standards and Global Vascular Guideline Recommendations

M Miah, A Bara, S Mahajan, S Ragavan, M Riaz, L Ogar, G McMahon

British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)

DOI: 10.1093/bjs/znag063.183 ↗

Kurz gefasst

Leitlinie in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von M Miah und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comprehensive best medical therapy (BMT) remains fundamental to the management of Chronic Limb-Threatening Ischaemia (CLTI). The 2023 European Society for Vascular Surgery (ESVS) guidelines advocate consistent provision of antiplatelet therapy, high-intensity statins, lipid profiling, blood pressure optimisation, and structured smoking cessation counselling. The Global Vascular Guidelines complement these recommendations by emphasising lifestyle modification and robust glycaemic assessment, including HbA1c testing within three months for diabetic or high-risk patients. This audit examined how closely current inpatient practice aligns with these combined guideline standards.

Method

A retrospective audit was undertaken over a 2-month period, reviewing consecutive inpatients with confirmed CLTI. Key measures included antiplatelet and statin prescription, completion of a lipid profile during admission, discharge blood pressure <140/90 mmHg, documentation of smoking cessation advice for active smokers, and availability of HbA1c within the previous three months.

Results

Of 35 CLTI inpatients, 80% received statin therapy and 60% received antiplatelet treatment. A lipid profile was completed in only 1 of 34 patients (2.9%). Blood pressure targets were achieved at discharge in 29 of 35 patients (82.9%). Smoking cessation counselling was documented in 5 of 36 active smokers (13.9%). HbA1c within three months was available in 14 of 49 diabetic patients (28.6%).

Conclusions

Adherence to evidence-based BMT and lifestyle optimisation in CLTI remains inconsistent, with notable gaps in lipid assessment, smoking cessation support, and glycaemic monitoring. Implementing structured clinical pathways, automated prompts, and routine lifestyle documentation may enhance delivery of guideline-directed care.

Zitieren

APA

Miah, M., Bara, A., Mahajan, S., Ragavan, S., Riaz, M., Ogar, L., & McMahon, G. (2026). 1058 Evaluating Comprehensive Best Medical Therapy and Lifestyle Optimisation in Chronic Limb-Threatening Ischaemia: An Integrated Audit of Adherence to ESVS 2023 Cardiovascular Standards and Global Vascular Guideline Recommendations. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.183

Vancouver

Miah M, Bara A, Mahajan S, Ragavan S, Riaz M, Ogar L, et al. 1058 Evaluating Comprehensive Best Medical Therapy and Lifestyle Optimisation in Chronic Limb-Threatening Ischaemia: An Integrated Audit of Adherence to ESVS 2023 Cardiovascular Standards and Global Vascular Guideline Recommendations. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.183

BibTeX
@article{Miah2026,
  author = {Miah, M and Bara, A and Mahajan, S and Ragavan, S and Riaz, M and Ogar, L and McMahon, G},
  title = {1058 Evaluating Comprehensive Best Medical Therapy and Lifestyle Optimisation in Chronic Limb-Threatening Ischaemia: An Integrated Audit of Adherence to ESVS 2023 Cardiovascular Standards and Global Vascular Guideline Recommendations},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_6},
  doi = {10.1093/bjs/znag063.183}
}
Kostenlos starten →